摘要
目的探究骨痨丸联合化疗方案治疗脊椎结核的临床疗效。方法基于本院自2012年1月-2015年1月收治的120例脊椎结核患者的临床资料,按照临床治疗方式的不同,随机将120例患者分为观察组（实施骨痨丸联合化疗方案治疗）和对照组（单纯的进行化疗治疗）,两组各60例,观察比较两组患者的临床治疗效果。结果观察组60例脊椎结核患者的临床治疗总有效率为98.33%（包括56例患者痊愈,3例患者临床治疗显效）高于对照组的85.00%（包括43例患者痊愈,8例患者临床治疗显效）（P〈0.05）,差异具有统计学意义。结论对脊椎结核患者进行骨痨丸联合化疗方案治疗,能够有效降低并发症发生率,全面推升脊椎结核患者的生存率及生活质量。
Objective To explore clinical efficacy of bone pill combined with chemotherapy in the treatment of spinal tuberculosis. Methods 120 cases of patients with spinal tuberculosis clinical data were treated in our hospital from January 2012 to January 2015, according to the clinical treatment of different random the 120 cases of patients were divided into observation group（the implementation of bone and joint tuberculosis pill combined with chemotherapy in the treatment） and control group（simple into received chemotherapy treatment）, 60 cases in each group, observed clinical therapeutic effects were compared between the two groups. Results Clinical observation group of 60 cases of patients with spinal tuberculosis total efficiency 98.33%（including 56 cases were cured, 3 cases of patients with clinical excellence） significantly higher than control group 85.00%（including 43 cases were cured, 8 cases patients clinical treatment markedly）（P〈0.05）, with statistical significance. Conclusion For patients with spinal tuberculosis were bone pill combined with chemotherapy in the treatment, can effectively reduce the incidence of complications, comprehensive push up the survival rate and quality of life of patients with spinal tuberculosis.
出处
《中国继续医学教育》
2016年第5期200-202,共3页
China Continuing Medical Education
关键词
骨痨丸
化疗
脊椎结核
临床疗效
并发症
Bone pill
Chemotherapy
Spinal tuberculosis
Clinical curative effect
Complication
